Researchers sought to identify candidate casual genes for Parkinson disease by integrating the genome-wide association study results with large-scale expression quantitative trait loci in 13 brain tissues.
Researchers evaluated the safety and efficacy of oral levosimendan, a calcium sensitizer, in patients with amyotrophic lateral sclerosis, and its ability to maintain respiratory function.
Researchers sought to investigate clinical predictors of the effect of subthalamic nucleus-deep brain stimulation on impulsive and compulsive behaviors in patients with Parkinson disease.
Researchers investigated the effects of a strength training program on function, activity, and participation in children and adolescents with cerebral palsy.
Researchers evaluated the 1-year safety data on subcutaneous levodopa/carbidopa continuous infusion with ND0612, an investigational subcutaneous delivery system providing minimally invasive continuous infusion, in patients with Parkinson disease.
Researchers shared their findings on the relationship between metabolic factors, like blood markers of lipid and carbohydrate metabolism, and the risk of developing amyotrophic lateral sclerosis.
In a study presented at MDS 2021, researchers assessed the progression of spinocerebellar ataxias type 1, 2, 3, and 6, an autosomal dominantly inheritance, to identify factors that influence the transition to higher disability.
In a study presented at MDS 2021, researchers assessed whether patients with tic disorders with or without major psychoses were at risk of developing tardive dyskinesia.
At MDS 2021, researchers shared study results on the effect of Parkinson disease (PD)-related genes on the risk for cardiovascular events among patients with genetic forms of PD, including those with variations in the LRRK2 and GBA genes.
At MDS 2021, researchers shared results of a genetics investigative analysis on variations in the BSN gene in patients with multiple system atrophy.